Christopher Moss joined the Moritz lab at ISB in 2013. His primary research focus has been using targeted proteomics to discover and validate biomarkers. His projects at ISB have included work on tuberculosis, chronic kidney disease, type 2 diabetes and Parkinson’s disease. He previously worked at the Proteomics Resource Center at Seattle Children’s Research Institute. He earned is PhD in 2011 from the University of Washington, Department of Chemistry.